Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.69 |
| ▸ | GAA | P10253 | 7/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.69 |
| ▸ | HTT | P42858 | 4/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | POLB | P06746 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GALK1 | P51570 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17688826 | 0.84 | HTT (0.65) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL17688827 | 0.84 | HTT (0.65) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL3597080 | 0.82 | MAPT (1.00) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL30089732 | 0.82 | KDM4E (0.45) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL20398470 | 0.82 | KDM4E (0.45) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL9627505 | 0.82 | EP300 (0.50) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL20398449 | 0.81 | ELANE (0.50) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL29372061 | 0.81 | ELANE (0.50) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL9628470 | 0.81 | MAPT (0.46) | MAPTGAAKDM4EHTTHSD17B10 | |
| SCHEMBL9627680 | 0.79 | HTT (0.54) | MAPTGAAKDM4EHTTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170260117-A1 | Method of Making Vitamin K1 | Sunny Pharmtech Inc. (TW) | 2017-09-14 | — | — | US | disclosed |
| US-20170260117-A1 | Method of Making Vitamin K1 | Sunny Pharmtech Inc. (TW) | 2017-09-14 | — | — | US | disclosed |
| WO-2016060670-A1 | METHOD OF MAKING VITAMIN K1 | Sunny Pharmtech Inc. (TW) | 2016-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170260117-A1 | Method of Making Vitamin K1 | PROC, VKORC1L1, VKORC1 | MAPT 4650/4885GAA 2110/4885KDM4E 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.